Role of gene polymorphisms in vitamin D metabolism and in multiple sclerosis

Open access

Abstract

Multiple sclerosis (MS) is a complex inflammatory disease of the central nervous system (CNS) resulting in neurological impairment and disability. There is evidence that adequate vitamin D levels may lower the risk of MS development. The aetiology of MS is complex and involves both genetic and environmental factors. In fact, not one but several genes are believed to lead to the disease. As for environmental factors, one of the most important risk factors is vitamin D deficiency, which, in turn, is closely related to gene polymorphisms that play a role in vitamin D metabolism and regulation. However, information about these gene polymorphisms is quite contradictory. The aim of this review is to discuss the association between some of the vitamin D-related gene variants and MS.

1. Abdollahzadeh R, Fard MS, Rahmani F, Moloudi K, Kalani BS, Azarnezhad A. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study. J Neurol Sci 2016;367:148-15. doi:

2. Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner- Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler J2012;18:16-22. doi:

3. Kallaur AP, Kaimen-Maciel DR, Morimoto HK, Watanabe MA, Georgeto SM, Reiche EM. Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). Int J Mol Med 2011;28:467-79. doi:

4. Ben-Selma W, Ben-Fredj N, Chebel S, Frih-Ayed M, Aouni M, Boukadida J. Age- and gender specific effects on VDR gene polymorphisms and risk of the development of multiple sclerosis in Tunisians: a preliminary study. Int J Immunogenet 2015;42:174-81. doi:

5. Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S, Panoulis C, Triantafyllou N. Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study. Neurol Sci 2013;34:1433-9. doi:

6. Harandi AA, Harandi AA, Pakdaman H, Sahraian MA. Vitamin D and multiple sclerosis. Iran J Neurol 2014;13:1-6. PMCID: PMC3968350

7. Summerday NM, Brown SJ, Allington DR, Rivey MP. Vitamin D and multiple sclerosis: review of a possible association. J Pharm Pract 2012;25:75-84. doi:

8. Agnello L, Scazzone C, Ragonese P, Salemi G, Lo Sasso B, Schillaci R, Musso G, Bellia C, Ciaccio M. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients. Neurol Sci 2016;37:261-7. doi:

9. Aranow C. Vitamin D and the immune system. J Investig Med 2011;59:881-6. doi:

10. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, Collins CE, Gilkeson GS, Diamond B, Hardin JA. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010;5(2):e9193. doi:

11. Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A, Salimi S. Vitamin D receptor gene polymorphism and the risk of multiple sclerosis in South Eastern of Iran. J Mol Neurosci 2015;56:572-6. doi:

12. Centers for Disease Control and Prevention (CDC). Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population; 2012 [displayed 2 March 2018]. Available at https://www.cdc.gov/nutritionreport/pdf/nutrition_book_complete508_final.pdf

13. Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, Csurhes P, Pender MP, Lea RA. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2009;19:25-38. doi:

14. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 2005;23:309-13. doi:

15. Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JWC, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009;8:621-6. doi:

16. Huang J, Xie ZF. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of casecontrol studies. J Neurol Sci 2012;313:79-85. doi:

17. Simon KC, Munger KL, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiplesclerosis. MultScler 2010;16:133-8. doi : 10.1177/1352458509355069

18. Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, Tashiro K. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999;166:47-52. PMID: 10465499

19. Fernandes de Abreu DA, Babron MC, Rebeix I, Fontenille C, Yaouanq J, Brassat D, Fontaine B, Clerget-Darpoux F, Jehan F, Feron F. Season of birth and not vitamin D receptor polymorphisms is a risk factor for multiple sclerosis. Mult Scler 2009;15:1146-52. doi:

20. Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 2011;305:116-20. doi:

21. Segal BM, Cohen JA, Antel J. Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2017: Environmental factors, genetics, and epigenetics in MS susceptibility and clinical courses. Mult Scler J 2018;24:4-5. doi:

22. Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol 2009;207:117-21. doi:

23. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143-56. doi:

24. Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL, Boggild MD, Ollier WE, Strange RC, Hawkins CP. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 2004;62:2323-5. doi:

25. Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, Fryer A, Hoban PR, Rukin N, Alldersea J, Strange RC, Hawkins CP. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler 2008;14:1280-3. doi:

26. McGrath JJ, Saha S, Burne TH, Eyles DW. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 2010;121:471-7. doi:

27. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, Taylor BV, McKay JD, Stankovich J, Dwyer T. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler 2009;15:563-70. doi:

28. Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 2000;54:729-32. doi:

29. García-Martín E, Agúndez JAG, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, Díaz-Sánchez M, Pisa D, Turpín-Fenoll L, Alonso-Navarro H, Ayuso-Peralta L, Torrecillas D, Plaza-Nieto JF, Jiménez-Jiménez FJ. Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One 2013;8(6):e65487. doi:

30. Čierny D, Michalik J, Škereňová M, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Lehotský J. ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks. Neurol Res 2016;38:678-84. doi:

31. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7. doi:

32. Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, Pelidou SH, Kyritsis AP, Fotopoulos A. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 2011;10:3. doi:

33. Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, Prada A, et al. HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler 2012;18:569-77. doi:

34. Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann NY Acad Sci 2009;1173:515-20. doi:

35. Al-Temaimi RA, Al-Enezi A, Al-Serri A, Al-Roughani R, Al-Mulla F. The association of vitamin D receptor polymorphisms with multiple sclerosis in a case-control study from Kuwait. PLoS One 2015;10(11):e0142265. doi:

36. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 2000;177:65-71. PMID: 10967184

37. Ling Y, Lin H, Aleteng Q, Ma H, Pan B, Gao J, Gao X. Cdx- 2 polymorphism in Vitamin D receptor gene was associated with serum 25-hydroxyvitamin D levels, bone mineral density and fracture in middle-aged and elderly Chinese women. Mol Cell Endocrinol 2016;427:155-61 doi:

38. Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K. Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol 2015;12:243-52. doi:

39. Handunnetthi L, Ramagopalan SV, Ebers GC. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 2010;74:1905-10. doi:

40. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, DeLuca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC. Expression of Multiple Sclerosis-associated MHC Class II allele HLA-DRB1*1501 is regulated by vitamin D. PLOSGenetics 2009;5(2):e1000369. doi:

41. GeneCards Human Gene Database [displayed 12 September 2017]. Available at http://www.genecards.org/cgi-bin/carddisp.pl?gene=CYP27B1

42. Australian and New Zealand Multiple Sclerosis Genetics Consortium. Genome-wide association study identifies new multiple sclerosis loci on chromosomes 12 and 20. Nat Genet 2009;41:824-30. doi:

43. Sundqvist E, Bäärnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I. Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet. 2010;18:1349-52. doi:

Archives of Industrial Hygiene and Toxicology

The Journal of Institute for Medical Research and Occupational Health

Journal Information


IMPACT FACTOR 2017: 1.117
5-year IMPACT FACTOR: 1.335



CiteScore 2017: 1.24

SCImago Journal Rank (SJR) 2017: 0.341
Source Normalized Impact per Paper (SNIP) 2017: 0.494

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 342 342 62
PDF Downloads 185 185 57